Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "2026"

716 News Found

Industrial AI takes center stage at ARC Industry Leadership India Forum 2026
Supply Chain | May 08, 2026

Industrial AI takes center stage at ARC Industry Leadership India Forum 2026

The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore


Pfizer powers ahead in 2026 with strong Q1 results as pipeline momentum builds
News | May 06, 2026

Pfizer powers ahead in 2026 with strong Q1 results as pipeline momentum builds

The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook


OBESITAS 2026 concludes with focus on India’s rising obesity burden
Healthcare | May 05, 2026

OBESITAS 2026 concludes with focus on India’s rising obesity burden

The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges


Indegene named leader in ISG provider lens 2026 for life sciences digital commercial operations
Digitisation | May 05, 2026

Indegene named leader in ISG provider lens 2026 for life sciences digital commercial operations

The ISG assessment highlights Indegene’s deep domain expertise, proprietary technology stack, and expanding use of AI and GenAI to drive more integrated, data-led commercial execution across the life sciences value chain


C-CAMP launches NBEC 2026 with up to Rs 20 Crore in prizes and investment opportunities
Biopharma | May 04, 2026

C-CAMP launches NBEC 2026 with up to Rs 20 Crore in prizes and investment opportunities

India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide


Moderna posts Q1 2026 loss despite revenue surge
News | May 04, 2026

Moderna posts Q1 2026 loss despite revenue surge

Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets


Bristol Myers Squibb begins 2026 with growth momentum
News | May 04, 2026

Bristol Myers Squibb begins 2026 with growth momentum

The company’s Growth Portfolio delivered $6.2 billion in revenue


Lilly posts explosive Q1 2026 results
News | May 04, 2026

Lilly posts explosive Q1 2026 results

Lifts full-year outlook as obesity drug boom accelerates


IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
Supply Chain | May 02, 2026

IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty

The company posted revenue of €1,267 million, up 6% on a constant currency basis


Merck posts mixed Q1 2026 results as blockbuster drugs drive growth
News | May 02, 2026

Merck posts mixed Q1 2026 results as blockbuster drugs drive growth

But acquisition charges drag earnings into loss